Fusion Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 34%.

Top 25 shareholders own 64.97% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.68%	Avidity Partners Management, L.P.	6,500,328	US$138.6m	12.4%	5.45%
7.56%	Deerfield Management Company, L.P. Series C	6,401,000	US$136.5m	127%	2.92%
6.27%	FMR LLC	5,313,294	US$113.3m	27.2%	0.01%
5.59%	Perceptive Advisors LLC	4,737,194	US$101.0m	72.2%	2.37%
4.5%	Odlander, Fredrikson & Co. AB	3,807,247	US$81.2m	0%	29.99%
4.33%	Johnson & Johnson Innovation - JJDC, Inc.	3,670,516	US$78.3m	0%	1.93%
3.85%	Siemens Aktiengesellschaft	3,256,972	US$69.4m	0%	no data
3.69%	OrbiMed Advisors LLC	3,122,770	US$66.6m	0%	0.99%
3.68%	Canada Pension Plan Investment Board	3,116,966	US$66.5m	0%	0.05%
3.48%	Adams Street Partners, LLC	2,947,809	US$62.8m	0%	18.18%
3.01%	TPG Capital, L.P.	2,551,794	US$54.4m	0%	0.2%
1.84%	Pivotal BioVenture Partners LLC	1,560,982	US$33.3m	0%	13.62%
1.28%	Sphera Funds Management Ltd	1,085,639	US$23.1m	-19.8%	3.82%
1.19%	Artal Group S.A.	1,005,500	US$21.4m	-41.7%	0.65%
1.17%	William Blair Investment Management, LLC	993,855	US$21.2m	0%	0.03%
0.88%	Wellington Management Group LLP	744,474	US$15.9m	0%	no data
0.87%	Scotia Asset Management L.P.	734,321	US$15.7m	0%	0.02%
0.68%	Eagle Health Investments LP	579,769	US$12.4m	0%	2.44%
0.68%	Millennium Management LLC	578,102	US$12.3m	-0.69%	0.01%
0.59%	Ikarian Capital, LLC	500,000	US$10.7m	0%	2.74%
0.5%	BlackRock, Inc.	419,806	US$9.0m	4,990%	no data
0.47%	Adage Capital Management, L.P.	400,000	US$8.5m	0%	0.02%
0.43%	Point72 Asset Management, L.P.	361,081	US$7.7m	9.79%	0.02%
0.38%	Marshall Wace LLP	318,440	US$6.8m	0%	0.02%
0.38%	John Valliant	318,147	US$6.8m	0%	no data